News

Medtech Milestones: 2000s


Posted in MDDI by Jamie Hartford on July 8, 2014

2000: A preliminary draft of genomes is completed by J. Craig Venter and Francis Collins.

 

 

 

 

 

 

 

 

 

 2002: The Medical Device User Fee and Modernization Act of 2002 allows FDA to collect user fees from sponsors for review activities.

2003: Cordis Corp.’s Cypher is the first drug-eluting stent approved in the United States.

 

 

 

 

 

 

 

 

 

2006: FDA lifts its 14-year ban on silicone gel breast implants.

 

 

 

 

 

 

 

 

 

 

2007: Five orthopedics manufacturers settle with the U.S. Department of Justice over allegations that they paid kickbacks to surgeons for favoring their hip and knee implants.

 

 

 

 

 

 

 

 

 

2008: AdvaMed updates its code of ethics to emphasize restrictions on promotional items and gifts, clarify guidelines on royalty arrangements, and create parameters for providing products for educational purposes.

 

1990s 2010–present

 

[images courtesy of COSMIN4000/iSTOCKPHOTO.COM, CORDIS CORP., WEBPHOTOGRAPHEER/iSTOCKPHOTO.COM, CHOJA/iSTOCKPHOTO.COM]

 


Tags:
Printer-friendly version
No votes yet

Login or register to post comments